Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomised study

This publication has 28 references indexed in Scilit:

• Modification of coronary artery disease progression by cholesterol-lowering therapy
  Current Opinion in Lipidology, 1999
• Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels
  New England Journal of Medicine, 1998
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
  The Lancet, 1998
• U.K. Prospective Diabetes Study 27: Plasma lipids and lipoproteins at diagnosis of NIDDM by age and sex
  Diabetes Care, 1997
• Cholesterol Lowering With Simvastatin Improves Prognosis of Diabetic Patients With Coronary Heart Disease: A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)
  Diabetes Care, 1997
• Myocardial infarct size and mortality in patients with non-insulin-dependent diabetes mellitus
  Journal of Internal Medicine, 1994
• Asymptomatic Hyperglycemia and Atherosclerotic Vascular Disease in the Elderly
  Diabetes Care, 1992
• Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS)
  The Lancet, 1992
• Hyperglycaemia and coronary heart disease: The Whitehall Study
  Journal of Chronic Diseases, 1979
• A series of papers by the International Collaborative Group, based on studies in fifteen populations
  Journal of Chronic Diseases, 1979